Criteria
Leader criteria
Sector
Communication Services
4
Consumer Discretionary
10
Consumer Staples
7
Energy
1
Financials
1
Health Care
10
Industrials
17
Information Technology
46
Materials
1
Real Estate
0
Utilities
4
Nasdaq-100
| Ticker ▲ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | Health Care | $165.00 | down 26.3% | down 33.1% | down 63.3% | 7.7% | 4 | 0/8 | $21.8B | 69.6× | — | up 73% | 27.7× | — | up 637% | 6/9 | Moderate | |
| AMGN | Amgen Inc | Health Care | $466.01 | up 6.1% | up 10.6% | up 64.0% | 2.5% | 90 | 8/8 | $251.1B | 32.6× | 0.37 | up 106% | 29.0× | 5.78 | up 65% | 7/9 | Moderate | |
| DXCM | Dexcom Inc | Health Care | $82.29 | up 5.6% | down 4.6% | up 20.7% | 3.2% | 65 | 6/8 | $31.7B | 37.9× | 0.79 | up 34% | 11.5× | — | up 3% | 8/9 | Low | |
| GEHC | Ge Healthcare Technologies Inc. | Health Care | $76.57 | up 7.2% | up 17.2% | up 2.2% | 2.7% | 59 | 3/8 | $35.1B | 16.9× | 3.52 | up 22% | 3.4× | 0.91 | up 39% | 5/9 | Moderate | |
| GILD | Gilead Sciences, Inc. | Health Care | $170.68 | up 9.4% | up 14.5% | up 46.8% | 2.6% | 87 | 7/8 | $211.8B | 24.9× | 0.01 | up 40% | 9.3× | 0.97 | down 20% | 8/9 | Low | |
| IDXX | Idexx Laboratories Inc /De | Health Care | $551.21 | down 1.6% | up 5.6% | down 12.3% | 2.8% | 30 | 1/8 | $43.9B | 41.5× | 1.84 | up 66% | 27.4× | 0.23 | up 18% | 8/9 | Low | |
| ISRG | Intuitive Surgical Inc | Health Care | $432.01 | down 4.5% | up 6.2% | down 18.5% | 3.0% | 40 | 2/8 | $153.4B | 53.7× | 2.36 | up 17% | 8.6× | — | down 24% | 7/9 | Low | |
| MRNA | Moderna, Inc. | Health Care | $221.72 | up 10.8% | up 15.1% | up 687.9% | 9.0% | 99 | 8/8 | $87.4B | — | — | down 29% | 10.1× | 0.07 | — | 2/9 | Low | |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | $927.89 | up 15.3% | up 22.4% | up 42.6% | 2.9% | 85 | 7/8 | — | — | — | up 15% | — | 0.06 | up 35% | — | Unknown | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | Health Care | $558.88 | up 6.7% | up 6.9% | up 33.1% | 2.7% | 81 | 8/8 | $142.0B | 35.9× | — | up 23% | 7.6× | — | up 8% | 8/9 | Low |